Cargando…
Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
BACKGROUND: According to clinical study results, immune checkpoint blockade (ICB) treatment enhances the survival outcome of patients with clear cell renal cell carcinoma (ccRCC). Previous research has divided ccRCC patients into immune subtypes with distinct ICB response rates. However, the study o...
Autores principales: | Wang, Zhifeng, Chen, Zihao, Guo, Tengyun, Hou, Menglin, Wang, Junpeng, Guo, Yanping, Du, Tao, Zhang, Xiaoli, Wang, Ning, Ding, Degang, Li, Xiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200973/ https://www.ncbi.nlm.nih.gov/pubmed/35719925 http://dx.doi.org/10.3389/fonc.2022.888502 |
Ejemplares similares
-
LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray
por: Yu, Gan, et al.
Publicado: (2012) -
LncRNAs and their role in cancer stem cells
por: Chen, Shusen, et al.
Publicado: (2017) -
Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
por: Wen, Jing, et al.
Publicado: (2020) -
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019) -
Comprehensive analysis of lncRNAs as biomarkers for diagnosis, prognosis, and treatment response in clear cell renal cell carcinoma
por: Chao, Xiaoyu, et al.
Publicado: (2021)